MHRA
- Status: likely_approved
Multiple-Visit-"Calcium Hydroxide" (Multiple-Visit-"Calcium Hydroxide") regulatory status in United Kingdom.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MHRA has authorised it; MHRA has authorised it; MHRA has authorised it.
Istanbul Medipol University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.